Glooko, Inc., a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum, today announced that Mark Clements, M.D., Ph.D., its Chief Medical and Strategy Officer, has been recognized by Becker’s Healthcare as one of its 2026 ‘Great leaders in healthcare.’
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260504609356/en/
The Becker’s recognition honors leaders whose work is helping shape the future of healthcare. Dr. Clements was recognized for the impact of his leadership in diabetes care, including his ability to bridge clinical practice, research, and digital innovation.
At Glooko, Dr. Clements helps guide the company’s clinical vision and strategy, ensuring that innovation remains grounded in evidence, aligned with clinical realities, and focused on better experiences and outcomes for individuals with diabetes and clinical teams. His leadership has helped strengthen Glooko’s clinical rigor, shape research collaboration, and advance a product strategy informed by science and real-world care needs.
“Dr. Clements brings deep credibility across medicine, research, and healthcare technology,” said Mike Alvarez, Chief Executive Officer of Glooko. “He helps translate complex clinical and data science insights into clear direction for our teams and keeps our work focused on meaningful impact for providers, health systems, and people living with diabetes. We are proud to see him recognized by Becker’s Healthcare.”
In addition to his work at Glooko, Dr. Clements is a respected leader in diabetes research and education. His contributions have helped advance more data-informed approaches to disease management and have improved care for people living with diabetes, including youth and underserved populations.
The full Becker’s Healthcare 2026 ‘Great leaders in healthcare’ list is available here.
About Glooko
Glooko is a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum. Glooko is uniquely positioned to be the enterprise partner of choice for healthcare providers seeking to reduce glycemic risk, improve safety, and support overburdened clinical teams with coordinated expertise across both outpatient and inpatient care settings.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260504609356/en/
Media gallery
